The Five-Stage Registration Process: From Pre-Evaluation to Release

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The actual Nicaraguan process for sanitary registration of devices has five stages: pre-evaluation, technical evaluation, issuance of the certificate, first-import quality check, and the release letter. The first three are governed by Articles 2, 4 and 6 of Chapter 7 of NTON 24001:2023 and by Articles 11 and 12 of Annex I of RA 0007/2025; the last two by Article 8 of Chapter 7 of NTON and Article 14 of Annex I. Even after the registration certificate is issued, the first-import quality check must be passed and the release letter obtained before the product may be freely commercialized — the date of issuance of the registration certificate is not the date from which sale may begin.

2. Legal basis

The five stages draw on the technical standard for their substance and on the administrative decision for the procedural counts. The key provisions are set out below.

LevelInstrumentProvisionKey point
Technical standardNTON 24001:2023, «Tecnología de la salud. Dispositivos médicos. Requisitos para el Registro Sanitario» (La Gaceta No. 192, 2024-10-21)Chapter 7, Articles 1 and 2The applicant submits all documents required by Chapter 6; the competent authority conducts a pre-evaluation, verifying that the required documents are complete
Technical standardNTON 24001:2023Chapter 7, Article 3If the pre-evaluation is rejected, the declarant has 15 working days to correct or supplement
Technical standardNTON 24001:2023Chapter 7, Articles 4 and 5After pre-evaluation is passed, technical evaluation begins; a rejection issues an Acta de Rechazo with 20 working days to correct, and no more than 2 rejections are allowed at this stage
Technical standardNTON 24001:2023Chapter 7, Article 6After evaluation is passed and approval granted, a registration certificate is issued and a unique and permanent number is assigned to the product
Technical standardNTON 24001:2023Chapter 7, Article 8On first import of a newly registered product, the DDM must be notified at the same time and analysis requested from the Quality Control Laboratory Directorate; the goods are held until the analysis results are issued
Administrative decisionAdministrative Resolution No. 0007/2025 (in force from 2025-05-02)Annex I, Article 12, item 8After approval of a new registration, a renewal or a post-registration change, the registration certificate is issued within a maximum of 3 working days
Administrative decisionAdministrative Resolution No. 0007/2025 (in force from 2025-05-02)Annex I, Article 14, item 8Once the first-import analysis is passed, the first-import release letter (carta de Autorización de Primera Importación) is issued within a maximum of 3 working days, and the registration thereby acquires full commercialization status

3. Expert insights

Insight 1: two of the five stages occur after the registration certificate is issued. Article 6 of Chapter 7 issues the certificate; Article 8 of Chapter 7 then opens the first-import quality check, and item 8 of Article 14 of Annex I issues the release letter. Treating the receipt of the registration certificate as the end of the project is the most common scheduling error in Nicaraguan projects — after issuance there remain four steps: applying for the quality check, on-site sampling, laboratory analysis and the release letter.

Insight 2: the release document does not have the same name for first import and for renewal. Checking the text of Annex I of RA 0007/2025 in this volume: item 8 of Article 14 (first import of a new registration) issues the «carta de Autorización de Primera Importación»; item 7 of Article 15 (market surveillance sampling after renewal) issues the «carta de Autorización de Comercialización». Both are issued within a maximum of 3 working days, but the names and the situations in which they apply differ, and they should not be used interchangeably when filing.

Insight 3: the window for applying for the first-import quality check is 15 working days after customs clearance. Note 1 of Article 14 of Annex I states «en un tiempo no mayor de 15 días hábiles posterior a la nacionalización del producto» — no more than 15 working days after nationalization of the product. The trigger is customs clearance of the goods, not the date the registration certificate was issued. The consequence of exceeding the period is that the DDM takes administrative measures within its powers; the provision does not list the specific measures.

Insight 4: the goods are held until the analysis results are available. Both Article 8 of Chapter 7 and item 3 of Article 14 of Annex I state «el producto estará retenido hasta que se obtengan resultados del análisis». This means the first-import batch cannot be sold or transferred before release.

Insight 5: there are two possible sampling bodies, which may attend separately or jointly — the health vigilance department of the DDM or the Quality Control Laboratory Directorate. Item 3 of Article 14 of Annex I says «o conjuntamente». Sampling takes place within the premises of the establishment («las instalaciones del establecimiento»), not at customs or in a third-party warehouse.

Insight 6: pre-evaluation and technical evaluation are different in nature. Article 2 of Chapter 7 says «se verifica el cumplimiento de los documentos requeridos» — compliance with the required documents is verified — which is a formal review; the technical content is examined at the evaluation stage. A rejection at pre-evaluation therefore normally means missing documents or formal defects, and should not be read as a technical rejection of the product.

4. Practical recommendations

  • Schedule across all five stages and do not treat certificate issuance as the end of the project: list the quality-check application, sampling, analysis and release letter as separate planned steps.
  • File the first-import quality-check application within 15 working days counted from the customs clearance date, and notify the DDM when the goods arrive (Chapter 7, Article 8).
  • Do not arrange sales or transfers of the first-import batch before the release letter is issued; manage the goods as held stock.
  • Distinguish the two release documents when filing: «Autorización de Primera Importación» for first import of a new registration, and «Autorización de Comercialización» for sampling after renewal.
  • When a pre-evaluation is rejected, treat it first as missing documents or a formal defect and check item by item against the 14-item documentation list of Chapter 6.
  • Pay the quality-check fee in advance at the current RM 347-2023 rate: Note 2 of Article 14 of Annex I requires payment before the quality-check application can be processed.

5. Verification checklist

  • □ Scheduled across the five stages, with the first-import quality check and release letter listed separately
  • □ Confirmed that the first-import quality-check application runs from the customs clearance date and filed within 15 working days
  • □ Notified the DDM of the arrival of the goods when they arrived (Chapter 7, Article 8)
  • □ Managed the first-import batch as held stock, with no sale or transfer before the release letter was issued
  • □ Paid the quality-check fee at the current RM 347-2023 rate and obtained the payment receipt
  • □ Filed release documents under the correct name, distinguishing the first-import release letter from the post-renewal release letter

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail